IBDEI21R ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34314,1,3,0)
 ;;=3^Secondary Parkinsonism,Other
 ;;^UTILITY(U,$J,358.3,34314,1,4,0)
 ;;=4^G21.8
 ;;^UTILITY(U,$J,358.3,34314,2)
 ;;=^5003777
 ;;^UTILITY(U,$J,358.3,34315,0)
 ;;=G25.0^^157^1744^8
 ;;^UTILITY(U,$J,358.3,34315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34315,1,3,0)
 ;;=3^Essential Tremor
 ;;^UTILITY(U,$J,358.3,34315,1,4,0)
 ;;=4^G25.0
 ;;^UTILITY(U,$J,358.3,34315,2)
 ;;=^5003791
 ;;^UTILITY(U,$J,358.3,34316,0)
 ;;=G25.1^^157^1744^6
 ;;^UTILITY(U,$J,358.3,34316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34316,1,3,0)
 ;;=3^Drug-Induced Tremor
 ;;^UTILITY(U,$J,358.3,34316,1,4,0)
 ;;=4^G25.1
 ;;^UTILITY(U,$J,358.3,34316,2)
 ;;=^5003792
 ;;^UTILITY(U,$J,358.3,34317,0)
 ;;=G25.2^^157^1744^22
 ;;^UTILITY(U,$J,358.3,34317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34317,1,3,0)
 ;;=3^Tremor,Other Spec Forms
 ;;^UTILITY(U,$J,358.3,34317,1,4,0)
 ;;=4^G25.2
 ;;^UTILITY(U,$J,358.3,34317,2)
 ;;=^5003793
 ;;^UTILITY(U,$J,358.3,34318,0)
 ;;=G25.3^^157^1744^11
 ;;^UTILITY(U,$J,358.3,34318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34318,1,3,0)
 ;;=3^Myoclonus
 ;;^UTILITY(U,$J,358.3,34318,1,4,0)
 ;;=4^G25.3
 ;;^UTILITY(U,$J,358.3,34318,2)
 ;;=^80620
 ;;^UTILITY(U,$J,358.3,34319,0)
 ;;=G25.69^^157^1744^20
 ;;^UTILITY(U,$J,358.3,34319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34319,1,3,0)
 ;;=3^Tics,Organic Origin,Other
 ;;^UTILITY(U,$J,358.3,34319,1,4,0)
 ;;=4^G25.69
 ;;^UTILITY(U,$J,358.3,34319,2)
 ;;=^5003797
 ;;^UTILITY(U,$J,358.3,34320,0)
 ;;=G25.61^^157^1744^5
 ;;^UTILITY(U,$J,358.3,34320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34320,1,3,0)
 ;;=3^Drug-Induced Tics
 ;;^UTILITY(U,$J,358.3,34320,1,4,0)
 ;;=4^G25.61
 ;;^UTILITY(U,$J,358.3,34320,2)
 ;;=^5003796
 ;;^UTILITY(U,$J,358.3,34321,0)
 ;;=G25.81^^157^1744^17
 ;;^UTILITY(U,$J,358.3,34321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34321,1,3,0)
 ;;=3^Restless Legs Syndrome
 ;;^UTILITY(U,$J,358.3,34321,1,4,0)
 ;;=4^G25.81
 ;;^UTILITY(U,$J,358.3,34321,2)
 ;;=^5003801
 ;;^UTILITY(U,$J,358.3,34322,0)
 ;;=R27.0^^157^1744^2
 ;;^UTILITY(U,$J,358.3,34322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34322,1,3,0)
 ;;=3^Ataxia,Unspec
 ;;^UTILITY(U,$J,358.3,34322,1,4,0)
 ;;=4^R27.0
 ;;^UTILITY(U,$J,358.3,34322,2)
 ;;=^5019310
 ;;^UTILITY(U,$J,358.3,34323,0)
 ;;=G24.9^^157^1744^7
 ;;^UTILITY(U,$J,358.3,34323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34323,1,3,0)
 ;;=3^Dystonia,Unspec
 ;;^UTILITY(U,$J,358.3,34323,1,4,0)
 ;;=4^G24.9
 ;;^UTILITY(U,$J,358.3,34323,2)
 ;;=^5003790
 ;;^UTILITY(U,$J,358.3,34324,0)
 ;;=G23.0^^157^1744^9
 ;;^UTILITY(U,$J,358.3,34324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34324,1,3,0)
 ;;=3^Hallervorden-Spatz Disease
 ;;^UTILITY(U,$J,358.3,34324,1,4,0)
 ;;=4^G23.0
 ;;^UTILITY(U,$J,358.3,34324,2)
 ;;=^5003779
 ;;^UTILITY(U,$J,358.3,34325,0)
 ;;=G90.3^^157^1744^10
 ;;^UTILITY(U,$J,358.3,34325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34325,1,3,0)
 ;;=3^Multi-Syst Degeneration of Autonomic Nervous System
 ;;^UTILITY(U,$J,358.3,34325,1,4,0)
 ;;=4^G90.3
 ;;^UTILITY(U,$J,358.3,34325,2)
 ;;=^5004162
 ;;^UTILITY(U,$J,358.3,34326,0)
 ;;=G21.11^^157^1744^12
 ;;^UTILITY(U,$J,358.3,34326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34326,1,3,0)
 ;;=3^Neuroleptic Induced Parkinsonism
 ;;^UTILITY(U,$J,358.3,34326,1,4,0)
 ;;=4^G21.11
 ;;^UTILITY(U,$J,358.3,34326,2)
 ;;=^5003772
 ;;^UTILITY(U,$J,358.3,34327,0)
 ;;=G21.19^^157^1744^4
 ;;^UTILITY(U,$J,358.3,34327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34327,1,3,0)
 ;;=3^Drug-Induced Secondary Parkinsonism
 ;;^UTILITY(U,$J,358.3,34327,1,4,0)
 ;;=4^G21.19
